Health News Illinois

Durbin unveils plan to limit drug hikes during “monopoly periods”

Pfizer And AstraZeneca's Billion Dollar Battle...Boxes containing various pharmaceutical products are seen on display in the pharmacy department of a drugstore in London, U.K., on Friday, May 2, 2014. AstraZeneca Plc rejected Pfizer Inc.'s sweetened takeover proposal, saying the 63.1 billion-pound ($106.5 billion) offer fails to recognize the value of the promising experimental medicines under development by the U.K.'s second-biggest drugmaker. Photographer: Chris Ratcliffe/Bloomberg

Sen. Dick Durbin, D-Ill., has unveiled a plan to crack down on drug price hikes of recently approved drugs.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
Exit mobile version